What is the EV/EBITDA ratio for Lexicon Pharmaceuticals, Inc. (LXRX)?

The EV/EBITDA ratio for LXRX stock is N/A.

What is the estimated TTM average EV/EBITDA ratio for Lexicon Pharmaceuticals, Inc. (LXRX)?

The estimated TTM average EV/EBITDA ratio for LXRX stock is 14.73x.

What is the estimated 3Y average EV/EBITDA ratio for Lexicon Pharmaceuticals, Inc. (LXRX)?

The estimated 3Y average EV/EBITDA ratio for LXRX stock is 4.34x.

What is the estimated 5Y average EV/EBITDA ratio for Lexicon Pharmaceuticals, Inc. (LXRX)?

The estimated 5Y average EV/EBITDA ratio for LXRX stock is 4.34x.

Lexicon Pharmaceuticals (LXRX) EV/EBITDA: History & Chart

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T15:52:04.575Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:52:04.575Z.

Quote observation: 2026-10-06T15:50:04.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 786,937,634
Total debt · period ending 2026-06-30: 59,279,000
Cash · period ending 2026-06-30: 40,924,000
TTM operating EBITDA · period ending 2026-06-30: -54,022,000

FMP input reference: d4371fef99df03934200e4dffcc755937dae78aec52c21603c02e47e686b1f66

EV/Sales|P/E Ratio|EBITDA|All Metrics

LXRX EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

EV/EBITDA RATIO AVG TTM

14.73x

EV/EBITDA RATIO AVG 3Y

4.34x

EV/EBITDA RATIO AVG 5Y

4.34x

EV/EBITDA RATIO AVG 10Y

N/A

EV/EBITDA RATIO AVG 15Y

N/A

EV/EBITDA RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

LXRX Competitors' EV/EBITDA Ratio

LXRX

Lexicon Pharmaceuticals, Inc.

Current

Market Cap

$786.94M

EV/EBITDA Ratio

N/A

TTM Avg

14.73x

3Y Avg

4.34x

5Y Avg

4.34x

GERN

Geron Corporation

vs LXRX

Market Cap

$789.07M

EV/EBITDA Ratio

N/A

TTM Avg

800.36x

3Y Avg

800.36x

5Y Avg

800.36x

GYRE

Gyre Therapeutics, Inc.

vs LXRX

Market Cap

$799.38M

EV/EBITDA Ratio

N/A

TTM Avg

76.03x

3Y Avg

57.10x

5Y Avg

57.10x

AHCO

AdaptHealth Corp.

vs LXRX

Market Cap

$796.23M

EV/EBITDA Ratio

6.66x

TTM Avg

5.45x

3Y Avg

14.30x

5Y Avg

12.03x

MLAB

Mesa Laboratories, Inc.

vs LXRX

Market Cap

$774.83M

EV/EBITDA Ratio

18.61x

TTM Avg

16.06x

3Y Avg

17.33x

5Y Avg

27.55x

ATTO

Attovia Therapeutics, Inc.

vs LXRX

Market Cap

$776.26M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

APMD

Apnimed, Inc.

vs LXRX

Market Cap

$804.23M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INMD

InMode Ltd.

vs LXRX

Market Cap

$803.93M

EV/EBITDA Ratio

5.90x

TTM Avg

7.11x

3Y Avg

8.26x

5Y Avg

13.78x

PACB

Pacific Biosciences of California, Inc.

vs LXRX

Market Cap

$816.88M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DSGN

Design Therapeutics, Inc.

vs LXRX

Market Cap

$767.14M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
Lexicon Pharmaceuticals, Inc. (LXRX)	$786.94M	N/A	14.73x	4.34x	4.34x
Geron Corporation (GERN)vs ›	$789.07M	N/A	800.36x	800.36x	800.36x
Gyre Therapeutics, Inc. (GYRE)vs ›	$799.38M	N/A	76.03x	57.10x	57.10x
AdaptHealth Corp. (AHCO)vs ›	$796.23M	6.66x	5.45x	14.30x	12.03x
Mesa Laboratories, Inc. (MLAB)vs ›	$774.83M	18.61x	16.06x	17.33x	27.55x
Attovia Therapeutics, Inc. (ATTO)vs ›	$776.26M	N/A	N/A	N/A	N/A
Apnimed, Inc. (APMD)vs ›	$804.23M	N/A	N/A	N/A	N/A
InMode Ltd. (INMD)vs ›	$803.93M	5.90x	7.11x	8.26x	13.78x
Pacific Biosciences of California, Inc. (PACB)vs ›	$816.88M	N/A	N/A	N/A	N/A
Design Therapeutics, Inc. (DSGN)vs ›	$767.14M	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/EBITDA Ratio FAQ

What is the EV/EBITDA ratio for Lexicon Pharmaceuticals, Inc. (LXRX)?: The EV/EBITDA ratio for LXRX stock is N/A.
What is the estimated TTM average EV/EBITDA ratio for Lexicon Pharmaceuticals, Inc. (LXRX)?: The estimated TTM average EV/EBITDA ratio for LXRX stock is 14.73x.
What is the estimated 3Y average EV/EBITDA ratio for Lexicon Pharmaceuticals, Inc. (LXRX)?: The estimated 3Y average EV/EBITDA ratio for LXRX stock is 4.34x.
What is the estimated 5Y average EV/EBITDA ratio for Lexicon Pharmaceuticals, Inc. (LXRX)?: The estimated 5Y average EV/EBITDA ratio for LXRX stock is 4.34x.

LXRX EV/EBITDA Ratio History

DATE	EV/EBITDA RATIO
2021-11-09	15.30x
2021-11-08	15.23x
2021-11-05	14.52x
2021-11-04	14.96x
2021-11-03	17.66x
2021-11-02	17.09x
2021-11-01	17.36x
2021-10-29	16.04x
2021-10-28	16.01x
2021-10-27	15.50x
2021-10-26	15.80x
2021-10-25	15.77x
2021-10-22	15.40x
2021-10-21	15.60x
2021-10-20	15.40x
2021-10-19	15.16x
2021-10-18	16.55x
2021-10-15	18.98x
2021-10-14	18.98x
2021-10-13	18.50x
2021-10-12	18.84x
2021-10-11	17.59x
2021-10-08	16.99x
2021-10-07	16.92x
2021-10-06	16.45x
2021-10-05	14.56x
2021-10-04	14.29x
2021-10-01	14.46x
2021-09-30	14.42x
2021-09-29	14.76x
2021-09-28	15.47x
2021-09-27	16.24x
2021-09-24	14.86x
2021-09-23	15.16x
2021-09-22	14.12x
2021-09-21	14.02x
2021-09-20	13.98x
2021-09-17	14.59x
2021-09-16	13.65x
2021-09-15	13.51x
2021-09-14	13.24x
2021-09-13	13.75x
2021-09-10	13.92x
2021-09-09	14.49x
2021-09-08	13.81x
2021-09-07	14.29x
2021-09-03	14.96x
2021-09-02	14.73x
2021-09-01	14.12x
2021-08-31	14.12x
2021-08-30	13.44x
2021-08-27	13.75x
2021-08-26	11.52x
2021-08-25	11.52x
2021-08-24	11.55x
2021-08-23	11.28x
2021-08-20	9.90x
2021-08-19	9.73x
2021-08-18	9.67x
2021-08-17	9.94x
2021-08-16	10.37x
2021-08-13	10.44x
2021-08-12	11.02x
2021-08-11	10.61x
2021-08-10	10.21x
2021-08-09	10.78x
2020-10-30	5.13x
2020-10-29	5.23x
2020-10-28	5.35x
2020-10-27	5.55x
2020-10-26	5.59x
2020-10-23	5.57x
2020-10-22	5.63x
2020-10-21	5.69x
2020-10-20	5.67x
2020-10-19	5.75x
2020-10-16	5.85x
2020-10-15	5.93x
2020-10-14	5.81x
2020-10-13	5.87x
2020-10-12	5.89x
2020-10-09	6.03x
2020-10-08	6.03x
2020-10-07	5.87x
2020-10-06	5.79x
2020-10-05	5.75x
2020-10-02	5.81x
2020-10-01	5.77x
2020-09-30	5.79x
2020-09-29	5.83x
2020-09-28	6.03x
2020-09-25	5.95x
2020-09-24	5.81x
2020-09-23	5.93x
2020-09-22	5.99x
2020-09-21	6.03x
2020-09-18	6.14x
2020-09-17	6.30x
2020-09-16	6.22x
2020-09-15	6.08x
2020-09-14	6.12x
2020-09-11	5.97x
2020-09-10	6.06x
2020-09-09	6.10x
2020-09-08	6.08x
2020-09-04	6.10x
2020-09-03	6.10x
2020-09-02	6.24x
2020-09-01	6.40x
2020-08-31	6.40x
2020-08-28	6.38x
2020-08-27	6.42x
2020-08-26	6.46x
2020-08-25	6.50x
2020-08-24	6.36x
2020-08-21	6.42x
2020-08-20	6.52x
2020-08-19	6.62x
2020-08-18	6.52x
2020-08-17	6.54x
2020-08-14	6.52x
2020-08-13	6.58x
2020-08-12	6.62x
2020-08-11	6.70x
2020-08-10	6.76x
2020-08-07	6.58x
2020-08-06	6.70x
2020-08-05	6.74x
2020-08-04	6.82x
2020-08-03	6.70x
2020-07-31	6.78x
2020-07-30	6.90x
2020-07-29	3.74x
2020-07-28	3.74x
2020-07-27	3.74x
2020-07-24	3.73x
2020-07-23	3.83x
2020-07-22	3.95x
2020-07-21	4.11x
2020-07-20	4.13x
2020-07-17	4.13x
2020-07-16	4.01x
2020-07-15	4.09x
2020-07-14	3.98x
2020-07-13	3.92x
2020-07-10	3.96x
2020-07-09	3.86x
2020-07-08	3.95x
2020-07-07	3.92x
2020-07-06	3.93x
2020-07-02	3.96x
2020-07-01	4.03x
2020-06-30	4.02x
2020-06-29	4.00x
2020-06-26	4.05x
2020-06-25	4.01x
2020-06-24	4.01x
2020-06-23	4.07x
2020-06-22	4.03x
2020-06-19	3.97x
2020-06-18	3.86x
2020-06-17	3.84x
2020-06-16	3.87x
2020-06-15	3.90x
2020-06-12	3.88x
2020-06-11	3.89x
2020-06-10	4.03x
2020-06-09	4.06x
2020-06-08	4.22x
2020-06-05	3.97x
2020-06-04	3.90x
2020-06-03	3.90x
2020-06-02	3.93x
2020-06-01	3.94x
2020-05-29	3.93x
2020-05-28	4.05x
2020-05-27	4.05x
2020-05-26	3.98x
2020-05-22	4.03x
2020-05-21	3.99x
2020-05-20	4.05x
2020-05-19	4.07x
2020-05-18	4.00x
2020-05-15	3.89x
2020-05-14	3.90x
2020-05-13	3.96x
2020-05-12	4.04x
2020-05-11	4.16x
2020-05-08	3.95x
2020-05-07	3.92x
2020-05-06	3.94x
2020-05-05	3.92x
2020-05-04	3.90x
2020-05-01	3.92x
2020-04-30	3.90x
2020-04-29	4.15x
2020-04-28	4.15x
2020-04-27	3.14x
2020-04-24	2.95x
2020-04-23	2.81x
2020-04-22	2.81x
2020-04-21	2.89x
2020-04-20	2.86x
2020-04-17	2.83x
2020-04-16	2.92x
2020-04-15	2.93x
2020-04-14	3.08x
2020-04-13	3.11x
2020-04-09	2.83x
2020-04-08	2.79x
2020-04-07	2.73x
2020-04-06	2.81x
2020-04-03	2.74x
2020-04-02	2.84x
2020-04-01	2.76x
2020-03-31	2.88x
2020-03-30	2.83x
2020-03-27	2.77x
2020-03-26	2.88x
2020-03-25	2.85x
2020-03-24	2.92x
2020-03-23	2.95x
2020-03-20	2.92x
2020-03-19	3.18x
2020-03-18	3.11x
2020-03-17	3.17x
2020-03-16	2.95x
2020-03-13	2.94x
2020-03-12	1.67x
2020-03-11	1.89x
2020-03-10	1.91x
2020-03-09	1.85x
2020-03-06	1.95x
2020-03-05	2.01x
2020-03-04	2.12x
2020-03-03	2.11x
2020-03-02	2.25x
2020-02-28	2.22x
2020-02-27	2.21x
2020-02-26	2.27x
2020-02-25	2.26x
2020-02-24	2.21x
2020-02-21	2.16x
2020-02-20	2.26x
2020-02-19	2.31x
2020-02-18	2.28x
2020-02-14	2.30x
2020-02-13	2.36x
2020-02-12	2.44x
2020-02-11	2.50x
2020-02-10	2.41x
2020-02-07	2.37x
2020-02-06	2.52x
2020-02-05	2.56x
2020-02-04	2.46x
2020-02-03	2.41x
2020-01-31	2.42x
2020-01-30	2.49x
2020-01-29	2.51x
2020-01-28	2.59x

Showing the most recent 260 of 351 data points. The chart above shows the full history.

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics

EV/EBITDA Ratio: N/A

LXRX EV/EBITDA Ratio Chart

LXRX Average EV/EBITDA Ratio Chart

LXRX EV/EBITDA Ratio Metrics

LXRX Competitors' EV/EBITDA Ratio

EV/EBITDA Ratio Formula & Definition

EV/EBITDA Ratio FAQ

LXRX EV/EBITDA Ratio History

Related Metrics